Research study Program year 2022 Source: CMS Open Payments

Phase IIB Prostate Combos PARP Enza Chemo

Research payments

$2,308,160

56 payments

Through program year 2022, $2,308,160 in research payments was reported against Phase IIB Prostate Combos PARP Enza Chemo, across 56 payments, paid by E.R. Squibb & Sons, L.L.C..

Paid by
E.R. Squibb & Sons, L.L.C.
ClinicalTrials.gov
No trial number was reported for this study

By program year

4 rows
Year Kind Amount Payments
2022 Research $27,307 2
2021 Research $420,763 17
2020 Research $555,464 19
2019 Research $1,304,626 18

Breakdown

Who paid Research payments · program years 2019–2022
  1. E.R. Squibb & Sons, L.L.C. $2,308,160 56 payments
Who received the money Research payments · program years 2019–2022
  1. Washington University Organisation paid for research $593,258 3 payments
  2. Us Oncology Res Llc Organisation paid for research $533,311 15 payments
  3. Duke Comp Cancer Cnt Organisation paid for research $266,200 3 payments
  4. Norton Hospitals Inc Teaching hospital · KY $231,463 3 payments
  5. Yale University Organisation paid for research $231,447 3 payments
  6. Desert Hematology Oncology Medical Group Organisation paid for research $111,323 3 payments
  7. Northwest Georgia Oncology Center, P C Organisation paid for research $86,012 3 payments
  8. Lehigh Valley Teaching hospital · PA $74,866 3 payments
  9. Columbia University Organisation paid for research $59,026 4 payments
  10. Karmanos Cancer Hospital Teaching hospital · MI $36,830 3 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record